MoneyWorks4Me

Medicamen Biotech informs about issuance of duplicate share certificates

05 Jun 2024 Evaluate

In terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Company has received request for issuance of duplicate share certificates in lieu of share certificates reported lost. The details of the share certificates reported lost are enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..